CIGNA members: Please note that you may receive a letter in the mail stating that The Dermatology Center of Indiana is no longer in your network. This communication from CIGNA is incorrect and we would like to reassure you that we are still in network with CIGNA. We look forward to continuing to service you and your family for all your dermatology needs.

2012

Psoriasis
Sponsor: Amgen
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
18 Years and Older
Phase: Phase 4
Start Date: February 2012
End Date: May 2015

Actinic Keratosis
Sponsor: LEO Pharma
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
18 Years and Older
Phase: Phase 3
Start Date: March 2012
End Date: July 2013

Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris Age Info Here
Phase: Phase 2
Start Date: May 2012
End Date: November 2012

Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 90100 in the Treatment of Psoriasis Vulgaris
18 Years and Older
Phase: Phase 2
Start Date: May 2012
End Date: November 2012

Psoriasis
Sponsor: Eli Lilly and Company
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
18 Years and Older
Phase: Phase 3
Start Date: May 2012
End Date: July 2019

Actively Extending Plaque Psoriasis
Sponsor: Idera Pharmaceuticals, Inc.
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
18-70 Years
Phase: Phase 2
Start Date: May 2012
End Date: December 2012

Acne Vulgaris
Sponsor: Intrepid Therapeutics, Inc.
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
12 Years and Older
Phase: Phase 2
Start Date: June 2012
End Date: February 2014

Papulopustular Rosacea
Sponsor: Bayer
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
18 Years and Older
Phase: Phase 3
Start Date: September 2012
End Date: January 2014

Actinic Keratosis
Sponsor: Teva Pharmaceuticals USA
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
18 Years and Older
Phase: Phase 3
Start Date: September 2012
End Date: August 2013